ArticleCancer biology & therapy2023

Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.

Yoon Sun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.